CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11

Clinical Science

Volumn 103, Issue SUPPL. 48, 2002, Pages

  Jeng, Arco Y ^a   Savage, Paula ^a   Beil, Michael E ^a   Bruseo, Charles W ^a   Hoyer, Denton ^a   Fink, Cynthia A ^a   Trapani, Angelo J ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

CGS 34226; ECE; Endothelin converting enzyme; Inhibitor; NEP; Neutral endopeptidase 24.11

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; CGS 34226; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ASSAY; ENZYME INHIBITION; KIDNEY DISEASE; NONHUMAN; PATHOGENESIS; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0036671885     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs103s098s     Document Type: Conference Paper

References (16)

1. Pathophysiology of endothelin in the cardiovascular system
2. Endothelins in the normal and diseased kidney
3. Endothelin system: The double-edged sword in health and disease
4. Endothelin-converting enzyme inhibitors and their effects
5. Non-peptidic endothelin converting enzyme inhibitors and their potential therapeutic applications
6. The biochemical pharmacology of atrial peptides
7. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney
8. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic
9. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans
10. Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1
11. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme
12. Purification and specificity of a membrane-bound metalloendopeptidase from bovine pituitaries
13. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1)
14. Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors
15. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats
16. The ACE inhibitors: Clinical pharmacology of captopril and enalapril